ID
13337
Description
Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00251368
Link
https://clinicaltrials.gov/show/NCT00251368
Keywords
Versions (1)
- 2/6/16 2/6/16 -
Uploaded on
February 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Leukemia, Myelocytic, Acute NCT00251368
Eligibility Leukemia, Myelocytic, Acute NCT00251368
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
bone marrow transplantation
Data type
boolean
Alias
- UMLS CUI [1]
- C0005961
Description
uncontrolled infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
hiv positivity
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Description
serious medical or psychiatric illness
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Similar models
Eligibility Leukemia, Myelocytic, Acute NCT00251368
- StudyEvent: Eligibility
C0277556 (UMLS CUI [1,2])
C0023449 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
C0280449 (UMLS CUI [3,1])
C0005699 (UMLS CUI [3,2])
C0856053 (UMLS CUI [4,1])
C0005699 (UMLS CUI [4,2])